Literature DB >> 4341015

Hepatic fructose-1,6-diphosphatase deficiency. A cause of lactic acidosis and hypoglycemia in infancy.

A S Pagliara, I E Karl, J P Keating, B I Brown, D M Kipnis.   

Abstract

An 8-month-old female, maintained on breast feeding for 6 months, experienced numerous attacks of hyperventilation when weaned to baby food and was admitted with severe lactic acidosis (20 mM) and hypoglycemia. Physical examination was negative except for hepatomegaly. Fasting (18 hr) after stabilization on a high carbohydrate diet resulted in hypoglycemia (plasma glucose 40 mg/100 ml), lactic acidosis (6-10 mM), and a rise in plasma alanine. Glucagon produced a glycemic response after 6 hr, but not after 18 hr fasting. Intravenous galactose increased plasma glucose (Delta 45 mg/100 ml) but intravenous fructose, glycerol, and alanine caused a 40-50% fall in plasma glucose and a significant rise in lactate (Delta 3-4 mM). Liver biopsy showed fatty infiltration. Liver slices incubated with galactose, lactate, fructose, alanine, or glycerol converted only galactose to glucose. Hepatic glycolytic intermediates were increased below the level of fructose-1,6-diphosphate and decreased above. Hepatic phosphorylase, glucose-6-phosphatase, amylo-1,6-glucosidase, phosphofructokinase, fructose-1-phosphate aldolase, and fructose-1,6-diphosphate aldolase levels were normal, but no fructose-1,6-diphosphatase (FDPase) activity was detected. Further studies on the liver homogenate of this patient revealed the presence of an acid-precipitable activator of FDPase. Normal plasma glucose and lactate levels were maintained on an 800 cal diet of 66% carbohydrate (sucrose and fructose excluded). 5% protein, and 20% fat. When carbohydrate was reduced to 35% and protein or fat increased to 23 and 53% respectively, lactic acidosis and hypoglycemia recurred. These studies show that a deficiency of FDPase produced infantile lactic acidosis and hypoglycemia and can be controlled by an appropriate diet.

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4341015      PMCID: PMC292368          DOI: 10.1172/JCI107018

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  22 in total

1.  Control of gluconeogenesis from amino acids in the perfused rat liver.

Authors:  L E Mallet; J H Exton; C R Park
Journal:  J Biol Chem       Date:  1969-10-25       Impact factor: 5.157

2.  Studies of liver glycogenoses, with particular reference to the metabolism of intravenously administered glycerol.

Authors:  B Senior; L Loridan
Journal:  N Engl J Med       Date:  1968-10-31       Impact factor: 91.245

3.  Immunological studies of liver, kidney, and muscle fructose 1,6-diphosphatases.

Authors:  M Enser; S Shapiro; B L Horecker
Journal:  Arch Biochem Biophys       Date:  1969-01       Impact factor: 4.013

4.  Natural activators for liver fructose 1,6-diphosphatase and the reversal of adenosine 5'-monophosphate inhibition by muscle phosphofructokinase.

Authors:  B M Pogell; A Tanaka; R C Siddons
Journal:  J Biol Chem       Date:  1968-04-10       Impact factor: 5.157

5.  Regulation of fructose diphosphatase activity by disulfide exchange.

Authors:  S Pontremoli; S Traniello; M Enser; S Shapiro; B L Horecker
Journal:  Proc Natl Acad Sci U S A       Date:  1967-07       Impact factor: 11.205

6.  Hormone-fuel interrelationships during fasting.

Authors:  G F Cahill; M G Herrera; A P Morgan; J S Soeldner; J Steinke; P L Levy; G A Reichard; D M Kipnis
Journal:  J Clin Invest       Date:  1966-11       Impact factor: 14.808

7.  Effects of changes in brain metabolism on the levels of citric acid cycle intermediates.

Authors:  N D Goldberg; J V Passonneau; O H Lowry
Journal:  J Biol Chem       Date:  1966-09-10       Impact factor: 5.157

8.  Carbohydrate supply as a regulator of rat liver phosphoenolpyruvate carboxykinase activity.

Authors:  E Schrago; J W Young; H A Lardy
Journal:  Science       Date:  1967-12-22       Impact factor: 47.728

9.  Enzymes of fructose metabolism in human liver.

Authors:  F Heinz; W Lamprecht; J Kirsch
Journal:  J Clin Invest       Date:  1968-08       Impact factor: 14.808

10.  Generation of extramitochondrial reducing power in gluconeogenesis.

Authors:  H A Krebs; T Gascoyne; B M Notton
Journal:  Biochem J       Date:  1967-01       Impact factor: 3.857

View more
  17 in total

1.  Congenital lactic acidosis due to pyruvate carboxylase deficiency: absence of an inhibitor of TPP-ATP phosphoryl transferase.

Authors:  K Tada; G Takada; K Omura; Y Itokawa
Journal:  Eur J Pediatr       Date:  1978-01-17       Impact factor: 3.183

Review 2.  Pharmaceutical excipients. Adverse effects associated with 'inactive' ingredients in drug products (Part II).

Authors:  L K Golightly; S S Smolinske; M L Bennett; E W Sutherland; B H Rumack
Journal:  Med Toxicol Adverse Drug Exp       Date:  1988 May-Jun

Review 3.  Investigational anti-hyperglycemic agents: the future of type 2 diabetes therapy?

Authors:  Sachin K Majumdar; Silvio E Inzucchi
Journal:  Endocrine       Date:  2013-01-25       Impact factor: 3.633

4.  Hepatic metabolites and uric acid excretion in fructose-1,6-diphosphatase deficiency.

Authors:  A Velázquez; C DeCéspedes; D C DeVivo; G Costin; K N Shaw
Journal:  J Inherit Metab Dis       Date:  1988       Impact factor: 4.982

5.  Hypoglycaemic effect of AICAriboside in mice.

Authors:  M F Vincent; M D Erion; H E Gruber; G Van den Berghe
Journal:  Diabetologia       Date:  1996-10       Impact factor: 10.122

6.  Impaired ketogenesis in fructose-1,6-bisphosphatase deficiency: a pitfall in the investigation of hypoglycaemia.

Authors:  A A Morris; S Deshphande; M P Ward-Platt; A E Whitfield; A Aynsley-Green; J V Leonard; M Pourfarzam; K Bartlett
Journal:  J Inherit Metab Dis       Date:  1995       Impact factor: 4.982

7.  Lactic acidemia, neurologic deterioration and carbohydrate dependence in a girl with dihydrolipoyl dehydrogenase deficiency.

Authors:  B H Robinson; J Taylor; S G Kahler; H N Kirkman
Journal:  Eur J Pediatr       Date:  1981-03       Impact factor: 3.183

8.  Deficiency of the iron-sulfur clusters of mitochondrial reduced nicotinamide-adenine dinucleotide-ubiquinone oxidoreductase (complex I) in an infant with congenital lactic acidosis.

Authors:  R W Moreadith; M L Batshaw; T Ohnishi; D Kerr; B Knox; D Jackson; R Hruban; J Olson; B Reynafarje; A L Lehninger
Journal:  J Clin Invest       Date:  1984-09       Impact factor: 14.808

9.  [Comparison of metabolic effects of infusions of glucose and glucose substitutes].

Authors:  H Förster
Journal:  Z Ernahrungswiss       Date:  1978-12

10.  Lactic acidosis, neurological deterioration and compromised cellular pyruvate oxidation due to a defect in the reoxidation of cytoplasmically generated NADH.

Authors:  B H Robinson; J Taylor; B Francois; A L Beaudet; D F Peterson
Journal:  Eur J Pediatr       Date:  1983-04       Impact factor: 3.183

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.